ClinicalTrials.gg
CompletedNCT04957784Updated Jul 12, 2021

Study on the Current Situation and Related Factors of Hypertension Management in a Poor County in Shanxi Province

An observational study in Hypertension, sponsored by Peking University Third Hospital. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-07-12.

Sponsored by Peking University Third Hospital · Observational

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
5,000
Ages
18 Years and older
Sex
All
01

Study summary

This project aims to understand the current situation of hypertension management in a poor county in Shanxi Province, and explore the factors that affect patients' blood pressure control based on local reality, and provide a basis for further promoting the standardized management of hypertension in poor areas and the comprehensive prevention and control of chronic diseases at the national grassroots level.

02

Conditions studied

  • Hypertension

Browse trials for

03

In context

Hypertension

6,834 studies on the registry are indexed under Hypertension; 971 are open to participants now.

This study's enrollment of 5,000 is above the median of 210 across 1,392 observational studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Peking University Third Hospital is the lead sponsor of 749 studies on the registry; 270 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Hypertensive population in a poverty-stricken county of Shanxi Province

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

(1)Clinical diagnosis of hypertension (2) Permanent population or floating population who have lived for more than 6 months in the area; (3) In the case of not taking antihypertensive drugs, after 3 different daily blood pressure measurements, the systolic blood pressure ≥140 mmHg and/or the diastolic blood pressure ≥90 mmHg were achieved in all 3 times, and it has been diagnosed by the community and above medical institutions in the past. Residents with high blood pressure; (4) As of October 2020, all research subjects have been included in the national basic public health service projects by medical institutions and have received standardized management of hypertension for one full year.

Exclusion criteria

Exclusion Criteria:

  1. Pregnant and lactating women;
  2. Those who are critically ill, mentally ill, cognitively impaired, etc.
05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
5,000 participants (actual)
Patient registry
No

Interventions

  • Otherquestionnaire survey

    Understand the current situation of hypertension management in a poor county in Shanxi Province through questionnaire surveys, and explore the factors that affect patients' blood pressure control based on local conditions

06

What researchers measure

Primary outcomes

  1. questionnaire survey

    General demographic characteristics, lifestyle, medication status, health knowledge awareness

    Time frame: 6 months

07

Study locations

1 site
  • Peking University Third Hospital
    Beijing, China
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2021 to primary completion in May 2021, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 29, 2021
First posted
Jul 12, 2021
StartActual
Feb 1, 2021
Primary completionActual
May 30, 2021
CompletionActual
May 31, 2021
Last update
Jul 12, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 12, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04957784
Responsible party
Sponsor
First posted
Jul 12, 2021
Start date
Feb 1, 2021
Primary completion
May 30, 2021
Completion
May 31, 2021
Last update
Jul 12, 2021

Study contacts

Gaiqi Yao
study chair · Peking University Third Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion